Litcius/Paper detail

Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells

Hao Shen, Yu Han, Qianyu Li, Ya-ting Wei, Jing Fu, Hui Dong, Dan Cao, Linna Guo, Lei Chen, Yuan Yang, Ying Xu, Mengchao Wu, Hongyang Wang, Yao Chen

2022Acta Pharmacologica Sinica56 citationsDOIOpen Access PDF

Topics & Concepts

Vascular endothelial growth factor AHepatocellular carcinomaHepatic stellate cellFatty liverCancer researchBiologyVascular endothelial growth factorMedicineInternal medicineDiseaseVEGF receptorsLiver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells | Litcius